|
|
|||||||||||
The British Journal of Psychiatry 159: 341-346 (1991)
© 1991 The Royal College of Psychiatrists
PJ Cowen, SL McCance, CJ Ware, PR Cohen, JS Chalmers and DL Julier
Psychopharmacology Research Unit, Littlemore Hospital, Oxford.
The addition of lithium to the tricyclic antidepressant medication of 23 patients with major depression resulted in an increase in the prolactin response to intravenous L-tryptophan after both four days and four weeks of treatment. The extent of this increase did not distinguish the ten patients who were classified as clinical responders (greater than 50% reduction in score on the HRSD). Among the responders there was a modestly significant correlation between the decrease in score on the HRSD and the enhancement of tryptophan-induced prolactin release. Some responders, however, showed very little change in this endocrine response over the four weeks of lithium treatment. Lithium may increase brain 5-HT function in tricyclic-resistant depression but there is only limited support for the hypothesis that changes in brain 5-HT function are involved in the antidepressant effect of this treatment combination.
This article has been cited by other articles:
![]() |
J. H. HUGHES, F. DUNNE, and A. H. YOUNG Effects of acute tryptophan depletion on mood and suicidal ideation in bipolar patients symptomatically stable on lithium The British Journal of Psychiatry, November 1, 2000; 177(5): 447 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Dinan Treatment approaches to therapy-resistant depression J Psychopharmacol, January 1, 1995; 9(2_suppl): 199 - 204. [Abstract] [PDF] |
||||
![]() |
P.J. Cowen Commentary on 'The management of treatment-resistant affective disorder: clinical perspectives' J Psychopharmacol, January 1, 1992; 6(2): 158 - 159. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |